Sprent, J., and H. Kishimoto. 2002. The thymus and negative selection. Immunol. Rev. 185:126-135.
Hogquist, K.A. 2001. Signal strength in thymic selection and lineage commitment. Curr. Opin. Immunol. 13:225-231.
Starr, T.K., S.C. Jameson, and K.A. Hogquist. 2003. Positive and negative selection of T cells. Annu. Rev. Immunol. 21:139-176.
Berg, L.J., and J. Kang. 2001. Molecular determinants of TCR expression and selection. Curr. Opin. Immunol. 13:232-241.
Winoto, A. 1997. Genes involved in T-cell receptor-mediated apoptosis of thymocytes and T-cell hybridomas. Semin. Immunol. 9:51-58.
Liu, Z.G., S.W. Smith, K.A. McLaughlin, L.M. Schwartz, and B.A. Osborne. 1994. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature. 367:281-284.
Woronicz, J.D., A. Lina, B.J. Calnan, S. Szychowski, L. Cheng, and A. Winoto. 1995. Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis. Mol. Cell. Biol. 15:6364-6376.
Weih, F., R. Ryseck, L. Chen, and R. Bravo. 1996. Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway. Proc. Natl. Acad. Sci. USA. 93:5533-5538.
Calnan, B.J., S. Szychowski, F.K. Chan, D. Cado, and A. Winoto. 1995. A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity. 3:273-282.
Youn, H.-D., L. Sun, R. Prywes, and J.O. Liu. 1999. Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. Science. 286:790-793.
Dequiedt, F., H. Kasler, W. Fischle, V. Kiermer, M. Weinstein, B.G. Herndier, and E. Verdin. 2003. HDAC7, a thymus-specinc class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis. Immunity. 18:687-698.
Verdin, E., F. Dequiedt, and H.G. Kasler. 2003. Class II histone deacetylases: versatile regulators. Trends Genet. 19:286-293.
Miska, E.A., C. Karlsson, E. Langley, S.J. Nielsen, J. Pines, and T. Kouzarides. 1999. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18:5099-5107.
Grozinger, C.M., and S.L. Schreiber. 2000. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. USA. 97:7835-7840.
Lu, J., T.A. McKinsey, R.L. Nicol, and E.N. Olson. 2000. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc. Natl. Acad. Sci. USA. 97:4070-4075.
Wang, A.H., M.J. Kruhlak, J. Wu, N.R. Bertos, M. Vezmar, B.I. Posner, D.P. Bazett-Jones, and X.J. Yang. 2000. Regulation of histone deacetylase 4 by binding of 14-3-3 proteins. Mol. Cell. Biol. 20:6904-6912.
Kao, H.-Y., A. Verdel, C.-C. Tsai, C. Simon, H. Juguilon, and S. Khochbin. 2001. Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7. J. Biol. Chem. 276:47496-47507.
McKinsey, T.A., C.L. Zhang, J. Lu, and E.N. Olson. 2000. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature. 408:106-111.
Zhang, C.L., T.A. McKinsey, S. Chang, C.L. Antos, J.A. Hill, and E.N. Olson. 2002. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell. 110:479-488.
Vertommen, D., M. Rider, Y. Ni, E. Waelkens, W. Merlevede, J.R. Vandenheede, and J. Van Lint. 2000. Regulation of protein kinase D by multisite phosphorylation. J. Biol. Chem. 275:19567-19576.
Nishikawa, K., A. Toker, F.-J. Johannes, Z. Songyang, and L.C. Cantley. 1997. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J. Biol. Chem. 272:952-960.
Davies, S.P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95-105.
Iglesias, T., N. Cabrera-Poch, M.P. Mitchell, T.J.P. Naven, E. Rozengurt, and G. Schiavo. 2000. Identification and cloning of Kidins220, a novel neuronal substrate of protein kinase D. J. Biol. Chem. 275: 40048-40056.
Wang, Y., R.T. Waldron, A. Dhaka, A. Patel, M.M. Riley, E. Rozengurt, and J. Colicelli. 2002. The RAS effector RIN1 directly competes with RAF and is regulated by 14-3-3 proteins. Mol. Cell. Biol. 22:916-926.
Van Lint, J., A. Rykx, Y. Maeda, T. Vantus, S. Sturany, V. Malhotra, J.R. Vandenheede, and T. Seufferlein. 2002. Protein kinase D: an intracellular traffic regulator on the move. Trends Cell Biol. 12:193-200.
Matthews, S.A., T. Iglesias, E. Rozengurt, and D. Cantrell. 2000. Spatial and temporal regulation of protein kinase D (PKD). EMBO J. 19:2935-2945.
Waldron, R.T., O. Rey, E. Zhukova, and E. Rozengurt. 2004. Oxidative stress induces protein kinase C-mediated activation loop phosphorylation and nuclear redistribution of protein kinase D. J. Biol. Chem. 279:27482-27493.
Rey, O., J. Sinnett-Smith, E. Zhukova, and E. Rozengurt. 2001. Regulated nucleocytoplasmic transport of protein kinase D in response to G protein-coupled receptor activation. J. Biol. Chem. 276:49228-49235.
Rey, O., J. Yuan, S.H. Young, and E. Rozengurt. 2003. Protein kinase C nu/protein kinase D3 nuclear localization, catalytic activation, and intracellular redistribution in response to G protein-coupled receptor agonists. J. Biol. Chem. 278:23773-23785.
Liljedahl, M., Y. Maeda, A. Colanzi, I. Ayala, J. Van Lint, and V. Malhotra. 2001. Protein kinase D regulates the fission of cell surface destined transport carriers from the trans-Golgi network. Cell. 104:409-420.
Prigozhina, N.L., and C.M. Waterman-Storer. 2004. Protein kinase D-mediated anterograde membrane trafficking is required for fibroblast motility. Curr. Biol. 14:88-98.
Yeaman, C., M.I. Ayala, J.R. Wright, F. Bard, C. Bossard, A. Ang, Y. Maeda, T. Seufferlein, I. Mellman, W.J. Nelson, and V. Malhotra. 2004. Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network. Nat. Cell Biol. 6:106-112.
Rennecke, J., P.A. Rehberger, G. Furstenberger, F.J. Johannes, M. Stohr, F. Marks, and K.H. Richter. 1999. Protein-kinase-Cmu expression correlates with enhanced keratinocyte proliferation in normal and neoplastic mouse epidermis and in cell culture. Int. J. Cancer. 80:98-103.
Zhukova, E., J. Sinnett-Smith, and E. Rozengurt. 2001. Protein kinase D potentiates DNA synthesis and cell proliferation induced by bombesin, vasopressin, or phorbol esters in Swiss 3T3 cells. J. Biol. Chem. 276:40298-40305.
Bowden, E.T., M. Barth, D. Thomas, R.I. Glazer, and S.C. Mueller. 1999. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene. 18:4440-4449.
Waldron, R.T., and E. Rozengurt. 2000. Oxidative stress induces protein kinase D activation in intact cells. J. Biol. Chem. 275:17114-17121.
Storz, P., and A. Toker. 2003. Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway. EMBO J. 22:109-120.
Matthews, S.A., E. Rozengurt, and D. Cantrell. 2000. Protein kinase D: a selective target for antigen receptors and a downstream target for protein kinase C in lymphocytes. J. Exp. Med. 191:2075-2082.
Marklund, U., K. Lightfoot, and D. Cantrell. 2003. Intracellular location and cell context-dependent function of protein kinase D. Immunity. 19:491-501.
Youn, H.D., and J.O. Liu. 2000. Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. Immunity. 13:85-94.
Winoto, A., and D.R. Littman. 2002. Nuclear hormone receptors in T lymphocytes. Cell. 109:S57-S66.
Kasler, H.G., J. Victoria, O. Duramad, and A. Winoto. 2000. ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain. Mol. Cell. Biol. 20:8382-8389.
Blaeser, F., N. Ho, R. Prywes, and T.A. Chatila. 2000. Ca2+-dependent gene expression mediated by MEF2 transcription factors. J. Biol. Chem. 275:197-209.
Haworth, R.S., MW. Goss, E. Rozengurt, and M. Avkiran. 2000. Expression and activity of protein kinase D/protein kinase C mu in myocardium: evidence for alpha1-adrenergic receptor- and protein kinase C-mediated regulation. J. Mol. Cell. Cardiol. 32:1013-1023.
Tsybouleva, N., L. Zhang, S. Chen, R. Patel, S. Lutucuta, S. Nemoto, G. DeFreitas, M. Entman, B.A. Carabello, R. Roberts, and A.J. Marian. 2004. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation. 109:1284-1291.
Fischle, W., S. Emiliani, M.J. Hendzel, T. Nagase, N. Nomura, W. Voelter, and E. Verdin. 1999. A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p. J. Biol. Chem. 274:11713-11720.
Fischle, W., F. Dequiedt, M.J. Hendzel, M.G. Guenther, M.A. Lazar, W. Voelter, and E. Verdin. 2002. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol. Cell. 9:45-57.
Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Second Edition. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 1626 pp.
Hawley, R.G., F.H. Lieu, A.Z. Fong, and T.S. Hawley. 1994. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1:136-138.
